BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26146958)

  • 1. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.
    Ma J; Lin Y; Zhan M; Mann DL; Stass SA; Jiang F
    Lab Invest; 2015 Oct; 95(10):1197-206. PubMed ID: 26146958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
    Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.
    Shen J; Todd NW; Zhang H; Yu L; Lingxiao X; Mei Y; Guarnera M; Liao J; Chou A; Lu CL; Jiang Z; Fang H; Katz RL; Jiang F
    Lab Invest; 2011 Apr; 91(4):579-87. PubMed ID: 21116241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis.
    Geng X; Tsou JH; Stass SA; Jiang F
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
    Zeng XL; Zhang SY; Zheng JF; Yuan H; Wang Y
    Chin Med J (Engl); 2013 Dec; 126(23):4510-6. PubMed ID: 24286416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
    Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K; Zhang T; Wang Y; Hao G
    World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Beacon for Detection miRNA-21 as a Biomarker of Lung Cancer.
    Alexandre D; Teixeira B; Rico A; Valente S; Craveiro A; Baptista PV; Cruz C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
    Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
    Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
    J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
    Su Y; Fang H; Jiang F
    Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis.
    Zhang X; Tan J; Chen Y; Ma S; Bai W; Peng Y; Shi G
    BMC Pulm Med; 2022 Dec; 22(1):479. PubMed ID: 36522766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.